Welcome

The Frederick National Laboratory for Cancer Research and COVID-19 serology testing

Read More View All
Study on “rapid autopsy” tumor tissue as a valuable research tool is among abstracts presented at 2020 ASCO Virtual Scientific Program

Read More View All
Ebola clinical trial supported by FNL receives “Trial of the Year” award

Read More View All
FNL Team Places Among Top Three in International Computing Contest

Read More View All
FNL RAS Investigators Take Published KRAS Study a Step Further, Share Findings in PNAS Letter to Editor

Read More View All

Science

State-of-the art research programs to meet special short and long-term needs of NCI and the cancer research community.

Technology

Advanced, next-generation technologies to solve basic and applied problems in the biomedical sciences.

Rapid Reponse

Effective and rapid response to emerging health threats and to changing national priorities in science and technology.

Doing Business

Providing a range of contractual agreement options with flexibility to facilitate the formation of partnerships.

Who We Are Discovery, innovation, and success in the biomedical sciences. Learn More

The Frederick National Laboratory is dedicated to improving human health through discovery and innovation in the biomedical sciences, focusing on cancer, AIDS, and emerging infectious diseases.

Our core values of accountability, compassion, collaboration, dedication, integrity, and versatility serve as a guidepost for how we do our work every day in serving the public's interest.

The Frederick National Laboratory for Cancer Research and COVID-19 serology testing

Study on “rapid autopsy” tumor tissue as a valuable research tool is among abstracts presented at 2020 ASCO Virtual Scientific Program

Ebola clinical trial supported by FNL receives “Trial of the Year” award

FNL Team Places Among Top Three in International Computing Contest

FNL RAS Investigators Take Published KRAS Study a Step Further, Share Findings in PNAS Letter to Editor